Minerva Neurosciences, Inc.
NERV
$1.67
-$0.055-3.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.27M | 22.51M | -8.23M | -8.57M | -9.02M |
| Total Depreciation and Amortization | 1.40K | 1.40K | 1.40K | 1.40K | 1.40K |
| Total Amortization of Deferred Charges | 0.00 | 4.30K | 6.40K | 6.40K | 6.40K |
| Total Other Non-Cash Items | 249.70K | -26.27M | 2.64M | 2.69M | 2.80M |
| Change in Net Operating Assets | -1.15M | -599.70K | 1.65M | -222.30K | 222.10K |
| Cash from Operations | -5.17M | -4.35M | -3.94M | -6.09M | -5.99M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | -- | -- | -- | -- | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.17M | -4.35M | -3.94M | -6.09M | -5.99M |